NasdaqGM - Delayed Quote USD

ANI Pharmaceuticals, Inc. (ANIP)

61.66
-0.25
(-0.40%)
At close: 4:00:01 PM EDT
61.66
0.00
(0.00%)
After hours: 4:20:00 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Nikhil Lalwani President, CEO & Director 2.44M 865.8k 1978
Mr. Stephen P. Carey Senior VP of Finance & CFO 1.14M -- 1971
Ms. Meredith W. Cook J.D. Senior VP, General Counsel & Corporate Secretary 845.5k -- 1974
Mr. Christopher K. Mutz Senior VP & Head of Rare Disease 919.66k -- 1972
Mr. Ori Gutwerg Senior Vice President of Generics 930.96k -- 1975
Mr. Muthusamy Shanmugam MS R.Ph. Head of R&D, COO of New Jersey Operations & Director -- -- 1968
Ms. Elizabeth Powell J.D. Chief Compliance Officer & Head of Legal of Rare Disease -- -- --
Mr. Chad Gassert Senior Vice President of Corporate Development & Strategy 849.71k -- 1976
Ms. Krista L. Davis Senior VP & Chief Human Resources Officer -- -- 1973
Dr. Mary Pao M.D., Ph.D. Chief Medical Officer -- -- --

ANI Pharmaceuticals, Inc.

210 Main Street West
Baudette, MN 56623
United States
218 634 3500 https://www.anipharmaceuticals.com
Sector: 
Healthcare
Full Time Employees: 
897

Description

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Corporate Governance

ANI Pharmaceuticals, Inc.’s ISS Governance QualityScore as of June 1, 2025 is 2. The pillar scores are Audit: 8; Board: 2; Shareholder Rights: 1; Compensation: 4.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 4, 2025 at 12:30 PM UTC - August 8, 2025 at 12:30 PM UTC

ANI Pharmaceuticals, Inc. Earnings Date

Recent Events

May 23, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 20, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 9, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 8, 2025 at 12:00 AM UTC

DEFA14A: Proxy Statements

April 10, 2025 at 12:00 AM UTC

DEF 14A: Proxy Statements

March 31, 2025 at 12:00 AM UTC

PRE 14A: Proxy Statements

March 18, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 14, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 11, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 28, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

Related Tickers